Why Is STEVANATO GROUP S P (STVN) Stock Up Today?

Stevanato Group SpA (STVN) shares rose 10.03% to $15.80, driven by the release of third-quarter financial results. The company reported non-GAAP earnings per share of €0.16 and revenue of €326.1 million. Management projects modest growth for 2027 despite a decline in GLP-1 syringe volumes.

What Happened

The stock’s move followed the disclosure of quarterly figures that indicated stable performance. The company outlined its outlook for the coming years, noting specific trends in its product mix. Analysts have recently adjusted their views on the stock. William Blair downgraded the shares to Market Perform. UBS maintained a Neutral rating but lowered its price target to $16. Citigroup kept its Buy rating while reducing its target to $20. A law firm is also investigating potential securities claims against the company.

What The Data Shows

The session opened at $14.67, a 2.2% gap from the prior close of $14.36. The stock reached a session high of $16.05 at 3:55 PM ET and a low of $14.40 at 10:00 AM ET. Trading volume reached 1.3 million shares, which is 2.3 times the three-month daily average. The company has a market capitalization of $3.8 billion and a P/E ratio of 24.9. Revenue has grown 6.6% over the trailing twelve months, with a net margin of 11.2%. The stock has a beta of 0.80 and a dividend yield of 0.44%. It currently trades within a 52-week range of $12.05 to $24.51. Over the last eight sessions, the stock has climbed 17.6% from $13.44 to $15.80. Recent insider activity includes two buys totaling $601,000 and one sale totaling $293,000. Directors William J. Federici and Donald E. Morel Jr. purchased shares in November 2026.

What To Watch

Investors will monitor the company’s execution on its 2027 growth projections. The recent surge in trading volume and the shift in analyst price targets provide key indicators for future price action.